The Problem with Delaying Measles Elimination

Author:

Crowcroft Natasha S.123ORCID,Minta Anna A.1,Bolotin Shelly2345,Cernuschi Tania1,Ariyarajah Archchun236,Antoni Sébastien1ORCID,Mulders Mick N.1ORCID,Bose Anindya S.1ORCID,O’Connor Patrick M.1

Affiliation:

1. Immunization, Vaccines and Biologicals, World Health Organization, 1211 Geneva, Switzerland

2. Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 3H2, Canada

3. Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON M5S 3H2, Canada

4. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 3H2, Canada

5. Public Health Ontario, Toronto, ON M5G 1V2, Canada

6. ICES, Toronto, ON M4N 3M5, Canada

Abstract

Measles is a highly infectious disease leading to high morbidity and mortality impacting people’s lives and economies across the globe. The measles vaccine saves more lives than any other vaccine in the Essential Programme of Immunization and is also the most cost-effective vaccine, with an extremely high return on investment. This makes achieving measles elimination through vaccination a key child health intervention, particularly in low-income countries, where the overwhelming majority of measles deaths continue to occur. All countries and regions of the world have committed to achieving measles elimination, yet many have faced challenges securing political commitment at national and global levels and predictable, timely, and flexible support from global donors, and experienced setbacks during the COVID-19 pandemic. This has happened against a backdrop of stagnant measles vaccination coverage and declining enthusiasm for vertical programmes, culminating in a World Health Organization Strategic Advisory Group of Experts (WHO SAGE) review of the feasibility of measles eradication in 2019. Sustaining the elimination of measles long term is extremely difficult, and some countries have lost or nearly lost their measles elimination status in the face of ongoing importation of cases from neighbouring or closely connected countries in which elimination had been delayed. Thus, a widening equity gap in measles immunisation coverage creates challenges for all countries, not just those facing the greatest burden of measles morbidity and mortality. Delaying elimination of measles in some countries makes it cumulatively harder for all countries to succeed for three principal reasons: increased inequity in measles immunisation coverage makes outbreaks more likely to happen and to be larger; political will is very difficult to sustain; and immunity may wane to a point that transmission is re-established. New strategies are needed to support countries and regions in their vision for a world without measles, including ways to galvanise domestic, regional and global resources and ignite the political will that is essential to make the vision a reality.

Funder

Canadian Institutes of Health Research

Canadian Immunization Research Network

Publisher

MDPI AG

Reference56 articles.

1. Measles and rubella elimination in the Eastern Mediterranean Region: Successes and challenges;Teleb;East. Mediterr. Health J.,2019

2. Risk analysis for the reintroduction and transmission of measles in the post-elimination period in the Americas;Lemos;Rev. Panam. Salud Publica,2017

3. The Expanded Program on Immunization in the English- and Dutch-speaking Caribbean (1977–2016): Reasons for its success;Irons;Rev. Panam. Salud Publica,2017

4. The State of Measles and Rubella in the WHO European region;Muscat;Rev. Esp. Salud Publica,2015

5. Progress toward Measles Elimination—World Health Organization Eastern Mediterranean Region, 2019–2022;Musa;Mmwr. Morb. Mortal. Wkly. Rep.,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3